MeaCor develops novel transcatheter devices for the treatment of heart disease.
MeaCor has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
MeaCor's investors include MedTech Innovator.
MeaCor is headquartered in Ayer, United States.
MeaCor develops novel transcatheter devices for the treatment of heart disease.
MeaCor is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MeaCor — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/meacor. Accessed September 6, 2026.
VCBacked. (2024). MeaCor — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/meacor
{{cite web |title=MeaCor — Funding & Investors |url=https://www.vcbacked.co/company/meacor |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated